.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
US Department of Justice
Argus Health
Baxter
Mallinckrodt
Daiichi Sankyo
Dow
Farmers Insurance
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075164

« Back to Dashboard
NDA 075164 describes VECURONIUM BROMIDE, which is a drug marketed by Sun Pharma Global, West-ward Pharms Int, Watson Labs, Mylan Labs Ltd, Hospira, Sagent Pharms, Teva Pharms Usa, and Gland Pharma Ltd, and is included in ten NDAs. It is available from ten suppliers. Additional details are available on the VECURONIUM BROMIDE profile page.

The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.

Summary for 075164

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 075164

Medical Subject Heading (MeSH) Categories for 075164

Suppliers and Packaging for NDA: 075164

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION 075164 ANDA Hospira, Inc. 0409-1632 0409-1632-01 10 VIAL in 1 CARTON (0409-1632-01) > 10 mL in 1 VIAL
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION 075164 ANDA Hospira, Inc. 0409-1634 0409-1634-01 10 VIAL in 1 CARTON (0409-1634-01) > 20 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Oct 21, 1999TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/VIAL
Approval Date:Oct 21, 1999TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Chinese Patent Office
Dow
Argus Health
Deloitte
Colorcon
Cipla
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot